| Name | Title | Contact Details |
|---|
SoftLayer Technologies, Inc. is one of the leading providers in Software and Internet. It is based in Dallas, TX. To find more information about SoftLayer Technologies, Inc., please visit www.softlayer.com.
Clearco is the world`s largest e-commerce investor providing equity free capital solutions to e-commerce businesses. Clearco`s gives founders real-time access to a global network of partners in addition to insights and data tools to help support them scale their business. Clearco has advanced more than $3.2 billion to more than 7000 brands, including Vanity Planet, Glamnetic, Public Goods, Soludos, and Monos. To date, Clearco has funded 25x more female Founders than the average traditional venture capital firm.
Freetrade is a UK-based financial technology company which offers a freemium share dealing service.
Attunity is a leading provider of big data management software solutions that enable access, management, sharing and distribution of data, including Big Data, across heterogeneous enterprise platforms, organizations, and the cloud. Our software solutions include data replication, data flow management, test data management, change data capture (CDC), data connectivity, enterprise file replication (EFR), managed file transfer (MFT), data warehouse automation, data usage analytics, and cloud data delivery. Attunity has supplied innovative software solutions to its enterprise-class customers for nearly 20 years and has successful deployments at thousands of organizations worldwide. Attunity provides software directly and indirectly through a number of partners such as Microsoft, Oracle, IBM and Hewlett Packard Enterprise. Headquartered in Boston, Attunity serves its customers via offices in North America, Europe, and Asia Pacific and through a network of local partners.
ClinCapture is the only validated electronic data capture software available to sponsors and CROs for free. As a leading cloud-based eClinical application, ClinCapture empowers its customers to build their own studies, lower their clinical trials costs...